Cidara Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
CDTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6310 Nancy Ridge Drive, Suite 101, San Diego, CA

Insiders trading volume in the past year

Cidara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director $35.5M Jan 3, 2025
Jeffrey Stein President & CEO, Director $1.12M +$106K +10.4% Mar 31, 2025
Shane Ward Coo & Clo $871K -$36.5K -4.03% Mar 31, 2025
Frank Karbe Chief Financial Officer $857K Feb 24, 2025
Leslie Tari Chief Scientific Officer $358K -$49.5K -12.2% Mar 11, 2025
Taylor Sandison Chief Medical Officer $268K -$10.8K -3.85% Sep 30, 2024
Preetam Shah Chief Financial Officer $232K Sep 30, 2024
Paul Daruwala Chief Operating Officer $210K Sep 12, 2022
Brady Johnson Vice President, Finance $56.3K Mar 31, 2022
Theodore R. Schroeder Director Dec 17, 2024
David L. Gollaher Director Jun 22, 2023
Chrysa Mineo Director Dec 17, 2024
Laura Tadvalkar Director Jul 18, 2024
James Merson Director Jul 18, 2024
Joshua Resnick Director Jan 3, 2025
Bonnie L. Bassler Director Dec 17, 2024
Carin Canale-Theakston Director Dec 17, 2024
Timothy R. Franson Director Jun 22, 2023
Daniel D. Burgess Director Dec 17, 2024
Ryan Spencer Director Jul 18, 2024

Recent Insider Transactions by Companies or Individuals for Cidara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.